Topics covered: The outlook for generics, The legality of authorized generics, The FDA approval process, Stocks to avoid., Stock recommendations, Patent challenges, Partnerships with Big Pharma, Options and earnings restatements, New product pipelines, Management performance, M&A Activity, Legal and regulatory outlook, Investor interest
Topics covered: Viable long-term holding, Restructuring activities, Re-engineer revenue growth, Peak-cycle conditions, Next cyclical direction in inventories, Low to midsingle-digit growth, Individual suppliers, Historical valuation perspectives, High-growth and high-margin model, Growth rate basis, Commodity service
Topics covered: The housing market, Tax legislation- Housing construction, Sector diversification benchmarking, IRAs, Income trusts in Canada, Globalization, Falling energy and commodity prices, Dividend stocks, Cell phone market
Topics covered: Volatility levels, US dollar/euro exchange rates, Silver exchange traded fund, Revenue-based royalties and taxation, Physical gold demand, Middle Eastern petrodollars, M&A Activity, Geopolitical issues, Exploration pipeline, ETFs, Chinese retail investment
Topics covered: Underperforming Chinese stock market, The cheapest expense ratio, Short-term negative event, Private equity money, Open-end mutual fund, Near-term price difficulty, Long/short equity fund, Larger-cap stocks, Individual micro-cap company, Independent wealth manager, Discounted cash flow model
